Lack of efficacy of maintenance interferon: Results of the HALT-C trial Bruce R. Bacon Clinical Trials Report 17 January 2009 Pages: 1 - 2
Role of growth factors and thrombopoietic agents in the treatment of chronic hepatitis C Hans L. TillmannKeyur PatelJohn G. McHutchison OriginalPaper 17 January 2009 Pages: 5 - 14
Treatment of chronic hepatitis C: Anticipated impact of resistance in patients treated with protease inhibitors Bernd KronenbergerStefan Zeuzem OriginalPaper 17 January 2009 Pages: 15 - 21
Treatment of chronic hepatitis B: Are we ready for combination therapy? Anil SeetharamMauricio Lisker-Melman OriginalPaper 17 January 2009 Pages: 22 - 27
Role of combination therapy in chronic hepatitis B John D. ScottBrian McMahon OriginalPaper 17 January 2009 Pages: 28 - 36
Small-duct primary sclerosing cholangitis Einar Björnsson OriginalPaper 17 January 2009 Pages: 37 - 41
Granulomatous liver disease Sidharth S. BhardwajRomil SaxenaPaul Y. Kwo OriginalPaper 17 January 2009 Pages: 42 - 49
Nonalcoholic fatty liver disease and cardiovascular risk Vijay Laxmi MisraMouen KhashabNaga Chalasani OriginalPaper 17 January 2009 Pages: 50 - 55
Portopulmonary hypertension Ravi P. NayakDechun LiGeorge M. Matuschak OriginalPaper 17 January 2009 Pages: 56 - 63
Hepatic assist devices: Will they ever be successful? Norman L. SussmanBrendan M. McGuireJames H. Kelly OriginalPaper 17 January 2009 Pages: 64 - 68
Treating hepatocellular carcinoma without liver transplantation Sudhanshu GogiaAlex S. Befeler OriginalPaper 17 January 2009 Pages: 69 - 75
The impact of MELD allocation on simultaneous liver-kidney transplantation Julie A. ThompsonJohn R. Lake OriginalPaper 17 January 2009 Pages: 76 - 82
Caring for adults with pediatric liver disease Michelle RookPhilip Rosenthal OriginalPaper 17 January 2009 Pages: 83 - 89
